Polar Power, Inc. POLA 深 滬
已收盤 10-17 16:00:00 美东时间
4.21
-0.830
-16.47%
華盛通- 最 高4.90
- 今 開4.90
- 成交量 5.16万股
- 最 低 4.06
- 昨 收 5.04
- 總市值 1057.34万
- 52周最高 5.7499
- 市盈率 靜 --
- 換手率 2.05%
- 52周最低 1.53
- 委 比 11.39%
- 總股本 251.15万
- 歷史最高 215.74
- 量 比 0.97
- 振 幅 16.67%
- 歷史最低 1.53
- 每 手 1
- 風險率 0.71%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多OCS各环节关键供应商梳理
（来源：君实财经） 电子时代的终结 1、这周OCS讨论度仍非常高 -我们在8月份Coherent和Lumentum季报后已重点提示OCS产业加速 -谷歌...
09-22 19:36
12 Industrials Stocks Moving In Thursday's Intraday Session
Gainers Concorde Intl Gr (NASDAQ:CIGL) shares rose 92.8% to $2.83 during Thurs...
09-05 01:05
Polar Power shares are trading higher after the company announced a partnership with ZQuip to develop and supply DC hybrid power systems for the construction equipment industry.
Polar Power shares are trading higher after the company announced a partnership...
09-04 21:51
Polar Power and ZQuip Collaborate to Develop and Supply DC Hybrid Power Systems for the Construction Equipment Industry
Polar Power Inc. (NASDAQ: POLA), a manufacturer of DC generators and battery charging systems, has teamed up with ZQuip, part of Moog Inc., to develop DC hybrid power systems for construction equipment. The collaboration aims to reduce emissions, noise, and operational costs at construction sites by introducing compact diesel-fueled charging systems. These modules, which can be used on mobile or stationary equipment, extend battery runtime, lower...
09-04 13:15
中金：维持亚盛医药-B跑赢行业评级 升目标价至105港元
中金发布研报称，维持亚盛医药-B（06855）2025年/2026年归母净利润预测不变，维持跑赢行业评级，考虑到GLORA-4进展，新适应症空间可见度提升...
08-25 12:09
中国血液肿瘤药物巨头起势，一场新盛宴的开始
（来源：氨基观察） 2025年，对中国创新药行业而言，其特殊性不仅在于全行业信心的集体回升，更体现在领军企业的蜕变：一批企业在这一年真正站上了新的起点。 以刚...
08-25 10:21
Polar Power Reports Q2 2025 Financial Decline
Polar Power ( ($POLA) ) has provided an announcement. On August 14, 2025, Polar...
08-15 18:46
Polar Power Q2 EPS $(0.11) Down From $0.20 YoY, Sales $2.708M Down From $4.660M YoY
Polar Power (NASDAQ:POLA) reported quarterly losses of $(0.11) per share. This is a 155 percent decrease over earnings of $0.20 per share from the same period last year. The company reported $2.708 million in sales this
08-15 04:24
食饮吾见 | 一周消费大事件（6.8-6.13）
酒业 *ST步森：拟换届改选事项与“西凤酒借壳上市”无关 近日，*ST步森发布关于收到控股股东提议换届选举提案函的风险提示性公告。当中提到，公司关注到，部分网络...
06-13 22:35
创新药大爆发！百济神州、亚盛医药国际多中心临床详解
（转自：摩熵医药大数据） 百济神州作为一家全球性生物制药公司，凭借其国际化的临床试验布局，在创新药物研发领域取得了显著成就，特别是其BTK抑制剂泽布替尼在A...
06-13 14:21
